Cargando…

Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey

OBJECTIVES: To evaluate outcomes and cost-effectiveness of targeted therapy sequencing for metastatic and recurrent cervical cancer. METHOD: Models were simulated based on phase II and III trials on bevacizumab (bev) from GOG-240, cemiplimab (cemi) from GOG 3016, pembrolizumab (pembro) from KEYNOTE-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Michael T., Attwood, Kristopher, Smith, Gabriella, Liang, Su-Ying, LaVigne Mager, Katherine, Tewari, Krishnansu S., Coleman, Robert L., Kapp, Daniel S., Chan, John K., Monk, Bradley J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469236/ https://www.ncbi.nlm.nih.gov/pubmed/37646470 http://dx.doi.org/10.1177/10732748231182795

Ejemplares similares

Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer
por: Eskander, Ramez N., et al.
Publicado: (2014)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Oncofertility in the setting of advanced cervical cancer - A case report
por: Gordon, Catherine, et al.
Publicado: (2018)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

Cervical cancer in Tanzania: A systematic review of current challenges in six domains
por: Runge, Ava S., et al.
Publicado: (2019)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study
por: Seamon, Leigh G, et al.
Publicado: (2018)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
por: Brueseke, Taylor J, et al.
Publicado: (2013)

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
por: Pearre, Diana C, et al.
Publicado: (2018)

Anti-angiogenesis therapy, synthetic lethality, and checkpoint inhibition in ovarian cancer: state of the science and novel combinations
por: Liu, Marisa C, et al.
Publicado: (2018)

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
por: Wolford, Juliet E., et al.
Publicado: (2017)

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
por: Tewari, Krishnansu S., et al.
Publicado: (2023)

Varying Phenotypes of Leydig Cell Hyperplasia of the Ovary: Two Case Reports
por: Caulkins, Margaret, et al.
Publicado: (2023)

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients
por: Woldemichael, Andinet, et al.
Publicado: (2016)

Lung cancer diagnosed on pap smear: A case report and review of the literature
por: Leaf, Marie-Claire, et al.
Publicado: (2021)

Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
por: Han, Xiling, et al.
Publicado: (2022)

Recurrent or primary metastatic cervical cancer: current and future treatments
por: Gennigens, C., et al.
Publicado: (2022)

Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management
por: Grisham, Rachel, et al.
Publicado: (2018)

Travelling under pressure - hypoxia and shear stress in the metastatic journey
por: Ildiz, Ece Su, et al.
Publicado: (2023)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery
por: LaVigne, Anna W., et al.
Publicado: (2017)

Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
por: Ercelep, Özlem, et al.
Publicado: (2020)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)

Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome
por: Eskander, Ramez N., et al.
Publicado: (2015)

Development of a patient journey map for people living with cervical dystonia
por: Benson, Monika, et al.
Publicado: (2022)

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study
por: Minion, Lindsey E., et al.
Publicado: (2016)

Metachronous metastatic colonic small cell carcinoma and recurrent adenocarcinoma in a patient with ulcerative colitis
por: Elias, Alexandra W, et al.
Publicado: (2017)

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
por: Mahdi, Haider, et al.
Publicado: (2023)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

Cervical extension of the thymus mimicking metastatic recurrence of Ewing sarcoma on PET/CT
por: Dua, Sumeet G, et al.
Publicado: (2010)

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review
por: Skelton, William Paul, et al.
Publicado: (2018)

De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening
por: Hahn, Erin E., et al.
Publicado: (2021)

Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey
por: Leurent, Baptiste, et al.
Publicado: (2018)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Response to “surgical management of cervical cancer by laparoscopy or laparotomy”
por: Leath, Charles A., et al.
Publicado: (2018)

Metastatic mastery: the uncommon journey of papillary thyroid carcinoma to the brain (a case report)
por: Rana, Deeksha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rqsud35317pji1l1biogfiai8u